172 related articles for article (PubMed ID: 33491154)
1. Upregulation of KIF11 in TP53 Mutant Glioma Promotes Tumor Stemness and Drug Resistance.
Liu B; Zhang G; Cui S; Du G
Cell Mol Neurobiol; 2022 Jul; 42(5):1477-1485. PubMed ID: 33491154
[TBL] [Abstract][Full Text] [Related]
2. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
3. High KIF11 expression is associated with poor outcome of NSCLC.
Liu J; Tian Y; Yi L; Gao Z; Lou M; Yuan K
Tumori; 2022 Feb; 108(1):40-46. PubMed ID: 33554761
[TBL] [Abstract][Full Text] [Related]
4. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
5. Kinesin family member 11 promotes progression of hepatocellular carcinoma via the OCT4 pathway.
Zhang J; Wei Z; Qi X; Jiang Y; Liu D; Liu K
Funct Integr Genomics; 2023 Aug; 23(3):284. PubMed ID: 37648881
[TBL] [Abstract][Full Text] [Related]
6. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Xia P; Li Q; Wu G; Huang Y
J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841
[TBL] [Abstract][Full Text] [Related]
7. KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers.
Hu ZD; Jiang Y; Sun HM; Wang JW; Zhai LL; Yin ZQ; Yan J
Biomed Res Int; 2021; 2021():2676745. PubMed ID: 33490265
[TBL] [Abstract][Full Text] [Related]
8. The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.
Venere M; Horbinski C; Crish JF; Jin X; Vasanji A; Major J; Burrows AC; Chang C; Prokop J; Wu Q; Sims PA; Canoll P; Summers MK; Rosenfeld SS; Rich JN
Sci Transl Med; 2015 Sep; 7(304):304ra143. PubMed ID: 26355032
[TBL] [Abstract][Full Text] [Related]
9. Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity.
Fischer NW; Prodeus A; Gariépy J
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089713
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.
Gu C; Banasavadi-Siddegowda YK; Joshi K; Nakamura Y; Kurt H; Gupta S; Nakano I
Stem Cells; 2013 May; 31(5):870-81. PubMed ID: 23339114
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
Yin H; Cui X
Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501
[No Abstract] [Full Text] [Related]
13. KIF11 As a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses.
Guo X; Zhou L; Wu Y; Li J
Oxid Med Cell Longev; 2022; 2022():2764940. PubMed ID: 36742345
[TBL] [Abstract][Full Text] [Related]
14. Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.
Blough MD; Beauchamp DC; Westgate MR; Kelly JJ; Cairncross JG
J Neurooncol; 2011 Mar; 102(1):1-7. PubMed ID: 20593219
[TBL] [Abstract][Full Text] [Related]
15. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
[TBL] [Abstract][Full Text] [Related]
16. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
17. A study on the correlation between STAT‑1 and mutant p53 expression in glioma.
Yang W; Wang H; Ju H; Dou C
Mol Med Rep; 2018 Jun; 17(6):7807-7812. PubMed ID: 29620180
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.
Xu LM; Chen L; Li F; Zhang R; Li ZY; Chen FF; Jiang XD
J Exp Clin Cancer Res; 2016 Oct; 35(1):162. PubMed ID: 27733185
[TBL] [Abstract][Full Text] [Related]
19. Linarin suppresses glioma through inhibition of NF-κB/p65 and up-regulating p53 expression in vitro and in vivo.
Zhen ZG; Ren SH; Ji HM; Ma JH; Ding XM; Feng FQ; Chen SL; Zou P; Ren JR; Jia L
Biomed Pharmacother; 2017 Nov; 95():363-374. PubMed ID: 28858735
[TBL] [Abstract][Full Text] [Related]
20. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]